EU Competition Law and Pharmaceuticals : New Horizons in Competition Law and Economics series - Wolf Sauter

EU Competition Law and Pharmaceuticals

By: Wolf Sauter (Editor), Marcel Canoy (Editor), Jotte Mulder (Editor)

Hardcover | 15 November 2022

At a Glance

Hardcover


$303.50

or 4 interest-free payments of $75.88 with

 or 

Aims to ship in 15 to 25 business days

This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.



The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels - in the context of current issues and future trends, including those related to COVID-19 - and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.



Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law.

Industry Reviews
'Pharmaceutical and vaccine markets are highly complex. In European healthcare systems, the state is the major purchaser, and so ordinary rules of competition law are insufficient in themselves to respond to the various dynamics at play: cost-effective innovation; access to medicines; burden on the public purse. But competition law is one of the aspects of the relevant regulatory toolkit, so it's crucial to understand how it applies. This cross-disciplinary and timely book goes well beyond the superficial, in its analysis and critique of contemporary developments and the direction of travel of European competition law as it applies to pharmaceuticals.' -- Tamara Hervey, City, University of London, UK

More in Competition Law & Antitrust Law

Australian Competition Law : 4th edition - Alex Bruce

RRP $134.00

$108.75

19%
OFF
Miller's Australian Competition Law & Policy 3rd Edition - Russell V. Miller
Derham on the Law of Set Off - Rory Derham
Competition Law in New Zealand - Chris Noonan

Not Supplied By Publisher

$243.75

Fintech Competition : Law, Policy, and Market Organisation - Konstantinos Stylianou
EU Competition Law : An Analytical Guide to the Leading Cases - Ariel Ezrachi
Competition Law - Richard Whish

RRP $149.99

$78.75

47%
OFF
Competition Law - Oxford Editor

RRP $463.25

$390.25

16%
OFF
Rethinking Merger Analysis - Louis Kaplow
Antitrust Law and Intellectual Property Rights : Cases and Materials - Christopher R. Leslie